(Q39449319)

12 September 2017

title

GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma (English)

1 reference

12 September 2017

1 reference

5

Angèle Gayet-Ageron

0 references

author name string

Fabienne Gumy-Pause

1

1 reference

12 September 2017

Bruno Pardo

2

1 reference

12 September 2017

Mary Khoshbeen-Boudal

3

1 reference

12 September 2017

Marc Ansari

4

1 reference

12 September 2017

Angèle Gayet-Ageron

5

1 reference

12 September 2017

André-Pascal Sappino

6

1 reference

12 September 2017

Edward F Attiyeh

7

1 reference

12 September 2017

Hulya Ozsahin

8

1 reference

12 September 2017

language of work or name

1 reference

1 November 2011

1 reference

Genes, Chromosomes and Cancer

12 September 2017

published in

1 reference

12 September 2017

volume

51

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

174-185

1 reference

Regulation of JNK signaling by GSTp

12 September 2017

cites work

1 reference

Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma

21 January 2018

1 reference

RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours

21 January 2018

1 reference

Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors.

21 January 2018

1 reference

Neuroblastoma: biological insights into a clinical enigma

21 January 2018

1 reference

Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma

21 January 2018

1 reference

Glutathione S-transferase pi regulates UV-induced JNK signaling in SH-SY5Y neuroblastoma cells

21 January 2018

1 reference

Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma

21 January 2018

1 reference

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report

21 January 2018

1 reference

Methylated genes as new cancer biomarkers.

21 January 2018

1 reference

Multigene methylation analysis for detection and staging of prostate cancer

21 January 2018

1 reference

Aberrant methylation of multiple genes in neuroblastic tumours. relationship with MYCN amplification and allelic status at 1p.

21 January 2018

1 reference

Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients.

21 January 2018

1 reference

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

21 January 2018

1 reference

Aberrant methylation of candidate tumor suppressor genes in neuroblastoma

21 January 2018

1 reference

Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.

21 January 2018

1 reference

MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas

21 January 2018

1 reference

Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines

21 January 2018

1 reference

Glutathione S-transferase polymorphisms and susceptibility to neuroblastoma.

21 January 2018

1 reference

Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma

21 January 2018

1 reference

Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary gland epithelial cells

21 January 2018

1 reference

Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma.

21 January 2018

1 reference

GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer

21 January 2018

1 reference

Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences

21 January 2018

1 reference

Methylation of tumour suppressor gene promoters in the presence and absence of transcriptional silencing in high hyperdiploid acute lymphoblastic leukaemia.

21 January 2018

1 reference

Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.

21 January 2018

1 reference

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

21 January 2018

1 reference

Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.

21 January 2018

1 reference

Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome

21 January 2018

1 reference

Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines

21 January 2018

1 reference

Reduction of GSTP1 expression by DNA methylation correlates with clinicopathological features in pituitary adenomas

21 January 2018

1 reference

Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease

21 January 2018

1 reference

Methylation profiles in breast cancer

21 January 2018

1 reference

7 January 2021

Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma

1 reference

7 January 2021

Glutathione S-transferases and prevention of cellular free radical damage

1 reference

7 January 2021

Methylation profiling of rectal cancer identifies novel markers of early-stage disease

1 reference

7 January 2021

Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas

1 reference

7 January 2021

Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors

1 reference

7 January 2021

Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome

1 reference

7 January 2021

Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma

1 reference

7 January 2021

1 reference

7 January 2021

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20941

1 reference

12 September 2017

1 reference